EB病毒诱导基因3在Th细胞免疫反应中的作用
摘要
EB病毒诱导基因3(epstein.Barrvirusinducedgene3,EBl3)是在EB病毒转化的B细胞培养上清液中发现的与细胞因子IL一12同源的可溶性细胞因子受体,在体内以同源二聚体、IL.27异源二聚体和IL一35异源二聚体3种形式存在。在免疫应答反应中,EBl3参与调节效应性T辅助细胞Thl、Th2和Thl7细胞的活化与分化,发挥抗感染和抗变应性炎症等调节作用。最近发现EBl3是调节性T细胞中Foxp3转录因子的下游靶分子,抑制调节性T细胞的分化和其免疫抑制活性,并与多种疾病的发病机制和免疫状态密切相关,是治疗感染性疾病、变应性疾病以及自身免疫性疾病的新靶点。
出处
《国际耳鼻咽喉头颈外科杂志》
2009年第6期360-363,共4页
International Journal of Otolaryngology-Head and Neck Surgery
基金
基金项目:国家自然科学基金(30872846)
北京市自然科学基金资助项目(7072017) 通信作者:欧阳昱晖,Email:oyyuhui@hotmail.tom
参考文献23
-
1Devergne O, Hummel M, Koeppen H, et al. Anovel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in Blymphocytes. JVirol, 1996, 70 (2) : 1143-1153.
-
2Hashimoto SI, Suzuki T, Nagai S, et al. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis ofgene expression. Blood, 2000, 96 (6) : 2206-2214.
-
3Devergne O, Coulomb-L'Hermine A, Capel F, et al. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40- related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol, 2001, 159 (5) : 1763-1776.
-
4Pflanz S, Hibbert L, Mattson J, et al. WSX-1 and glycoprotein 130 constitute a signal transducing receptor for IL-27. J Immunol, 2004, 172 (4) : 2225-2231.
-
5Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Thl responses. Trends lmmunol, 2003, 24 (4) : 207-212.
-
6Yoshida H, Hamano S, Senaldi G, et al. WSX-1 is required for the initiation of Thl responses and resistance to L. major infection. Immunity, 2001, 15 (4) : 569-578.
-
7Kamiya S, Owaki T, Morishima N, et al. An indispensable role for STATI in IL-27-induced T-bet expression but not proliferation of naive CD4^+T cells. J Immunol, 2004, 173 (6) : 3871-3877.
-
8Owaki T, Asakawa M, Morishima N, et al. A role for IL-27 in early regulation of Thl differentiation. J Immunol, 2005, 175 (4) : 2191-2200.
-
9Lucas S, Ghilardi N, Li J, et al. IL-27 regulates IL-12 responsiveness of naive CD4^+ T cells through Statl-dependent and- independent mechanisms. Proc Natl Acad Sci USA, 2003, 100 (25) : 15047-15052.
-
10Villarino AV, Stumhofer JS, Saris C J, et al. IL-27 limits IL-2 production during Thl differentiation. J Immunol, 2006, 176 (1) : 237-247.
二级参考文献39
-
1陈万军 ,张烜 .CD_4^+CD_(25)^+T免疫调节细胞在疾病发生和临床应用中的意义[J].中华医学杂志,2005,85(41):2948-2951. 被引量:14
-
2罗征秀,刘恩梅,邓兵,李欣,陈坤华,王莉佳,黄英,符州.Foxp3表达与CD_4^+CD_(25)^+调节性T细胞在儿童哮喘发病中的作用[J].中华儿科杂志,2006,44(4):267-271. 被引量:41
-
3Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995,155:1151- 1164.
-
4Brunkow M E, Jeffery E W, Hjerrild K A, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse[ J]. Nat Genet, 2001,27:68-73.
-
5Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by The transcription factor Foxp3[J]. Science, 2003,299 : 1057- 1061.
-
6Bluestone J A. Regulatory T-cell therapy: is it ready for the clinic[ J]. Nat Rev Immunol, 2005,5:343-349.
-
7Ling E M, Smith T, Nguyen X D, et al. Relation of CD4 + CD25 + regulatory T-cell suppression of allergen-driven T- cell activation to atopic status and expression of allergic disease[ J]. Lancet, 2004,363:608-615.
-
8Fougeray S, Brignone C, Triebel F. A soluble LAG-3 protein as an immunopotentiator for Therapeutic vaccines: Preclinical evaluation of IMP321 [ J ]. Vaccine. 2006, 24 : 5426-5433.
-
9Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asThma[J]. J Allergy Clin Immunol, 2004,114: 1425- 1433.
-
10Doganci A, Eigenbrod T, Krug N, et al. The IL-6R alpha chain controls lung CD4 + CD25 + Treg development and function during allergic airway inflammation in vivo [ J]. J Clin Invest, 2005,115 : 313025.
共引文献8
-
1范尔钟,锡琳,韩德民,张盛忠,李颖,张罗.铝佐剂在建立变应性鼻炎动物模型中的安全性研究[J].中华耳鼻咽喉头颈外科杂志,2009,44(8):664-668. 被引量:8
-
2杨春平,罗英,刘月辉.辅助性T17细胞和调节性T细胞与变应性鼻炎[J].国际耳鼻咽喉头颈外科杂志,2011,35(2):83-86.
-
3杨春平,罗英,刘月辉.Th17/Treg细胞与变应性鼻炎的研究进展[J].重庆医学,2011,40(26):2685-2687. 被引量:4
-
4李烁,洪海裕,李小敏,高进良,高春生,赵家利,刘邦华.特异性免疫治疗对变应性鼻炎外周血CD4+CD25+T调节细胞的影响及远期疗效的观察[J].中山大学学报(医学科学版),2013,34(4):607-612. 被引量:15
-
5曾德容,刘军.电针对变应性鼻炎患者免疫功能的影响观察[J].世界中医药,2016,11(3):519-522. 被引量:3
-
6宋秋灵.FOXP3基因多态性与变应性鼻炎的相关性研究[J].国际免疫学杂志,2016,39(2):139-142.
-
7张杨,甄宏韬.Th17细胞和Treg细胞与变态反应性气道疾病[J].中华临床医师杂志(电子版),2012,6(22):7330-7333.
-
8施华丽,杨晓峰.低氧诱导因子-1α通路在成骨细胞及破骨细胞耦联中的调控效果探讨[J].世界最新医学信息文摘,2016,16(64):57-58. 被引量:1
-
1袁芳,杜小萍(综述),鞠吉雨(审阅).新型抑制性细胞因子IL-35研究进展[J].现代免疫学,2009,29(4):348-351. 被引量:5
-
2李婧瑶,刘晓颖,范礼斌.哺乳动物细胞中EB病毒诱导基因3的定位及表达[J].安徽医科大学学报,2013,48(4):333-336.
-
3刘增荣(综述),刘剑平(审校).Toll样受体与EB病毒感染研究进展[J].医学综述,2009,15(13):1935-1937.
-
4姜雪明.细胞因子IL-35的研究进展[J].中国妇幼健康研究,2016,27(S1):576-577. 被引量:2
-
5林歆胜,王挥戈.树突状细胞和T细胞的相互作用与变应性疾病[J].国际耳鼻咽喉头颈外科杂志,2008,32(2):70-73. 被引量:1
-
6顾一利,张罗.调节性T细胞在肿瘤免疫中的作用[J].国际耳鼻咽喉头颈外科杂志,2010,34(2):115-118.
-
7查士隽,谢蜀生.抗抑制调节[J].国外医学(免疫学分册),1989,12(6):297-300.
-
8任艳鑫,隋军,李晓江,马静.CD4+CD25+T细胞与头颈肿瘤[J].国际耳鼻咽喉头颈外科杂志,2008,32(1).
-
9李伟林,董秋美.双吻合器在保留自主神经直肠癌根治术的应用[J].中国现代手术学杂志,2016,20(3):175-178. 被引量:3
-
10杨小华,张立煌,曹雪涛.可溶性细胞因子受体与疾病发生发展以及治疗的研究进展[J].国外医学(免疫学分册),2005,28(1):48-51. 被引量:6